Insider Transactions in Q3 2023 at Nuvalent, Inc. (NUVL)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 15
2023
|
Deborah Ann Miller Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,000
-81.1%
|
$94,000
$47.71 P/Share
|
|
Sep 15
2023
|
Deborah Ann Miller Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
$12,000
$6.89 P/Share
|
|
Sep 01
2023
|
Darlene Noci Chief Development Officer |
SELL
Open market or private sale
|
Direct |
3,000
-70.0%
|
$138,000
$46.49 P/Share
|
|
Sep 01
2023
|
Darlene Noci Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+50.0%
|
$3,000
$1.08 P/Share
|
|
Aug 15
2023
|
Deborah Ann Miller Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,000
-82.28%
|
$84,000
$42.73 P/Share
|
|
Aug 15
2023
|
Deborah Ann Miller Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
$12,000
$6.89 P/Share
|
|
Aug 01
2023
|
Darlene Noci Chief Development Officer |
SELL
Open market or private sale
|
Direct |
3,000
-66.07%
|
$147,000
$49.88 P/Share
|
|
Aug 01
2023
|
Darlene Noci Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+50.0%
|
$3,000
$1.08 P/Share
|
|
Jul 31
2023
|
Alexandra Balcom Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
25,000
-78.3%
|
$1,225,000
$49.05 P/Share
|
|
Jul 31
2023
|
Alexandra Balcom Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+50.0%
|
$25,000
$1.08 P/Share
|
|
Jul 28
2023
|
Deborah Ann Miller Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
6,500
-100.0%
|
$312,000
$48.52 P/Share
|
|
Jul 28
2023
|
Deborah Ann Miller Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+50.0%
|
$39,000
$6.89 P/Share
|
|
Jul 28
2023
|
Christopher Durant Turner Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,665
-15.51%
|
$127,920
$48.93 P/Share
|
|
Jul 28
2023
|
Christopher Durant Turner Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,665
+13.43%
|
$15,990
$6.89 P/Share
|
|
Jul 26
2023
|
Christopher Durant Turner Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,365
-14.01%
|
$108,790
$46.85 P/Share
|
|
Jul 26
2023
|
Christopher Durant Turner Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,365
+12.29%
|
$14,190
$6.89 P/Share
|
|
Jul 24
2023
|
Christopher Durant Turner Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
200
-1.36%
|
$9,200
$46.82 P/Share
|
|
Jul 24
2023
|
Christopher Durant Turner Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
200
+1.34%
|
$1,200
$6.89 P/Share
|
|
Jul 20
2023
|
Christopher Durant Turner Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
100
-0.68%
|
$4,600
$46.8 P/Share
|
|
Jul 20
2023
|
Christopher Durant Turner Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
100
+0.68%
|
$600
$6.89 P/Share
|
|
Jul 20
2023
|
Darlene Noci Chief Development Officer |
SELL
Open market or private sale
|
Direct |
10,941
-100.0%
|
$492,345
$45.17 P/Share
|
|
Jul 20
2023
|
Darlene Noci Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,941
+50.0%
|
$10,941
$1.08 P/Share
|
|
Jul 19
2023
|
Darlene Noci Chief Development Officer |
SELL
Open market or private sale
|
Direct |
4,559
-100.0%
|
$205,155
$45.04 P/Share
|
|
Jul 19
2023
|
Darlene Noci Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,559
+50.0%
|
$4,559
$1.08 P/Share
|
|
Jul 17
2023
|
Deborah Ann Miller Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,000
-63.96%
|
$84,000
$42.74 P/Share
|
|
Jul 17
2023
|
Deborah Ann Miller Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
$12,000
$6.89 P/Share
|
|
Jul 03
2023
|
Darlene Noci Chief Development Officer |
SELL
Open market or private sale
|
Direct |
3,000
-90.78%
|
$123,000
$41.73 P/Share
|
|
Jul 03
2023
|
Darlene Noci Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+50.0%
|
$3,000
$1.08 P/Share
|